REYATAZ is a protease inhibitor that has been studied in both treatment-naïve and treatment-experienced HIV-1-infected patients and is administered once daily as part of combination HIV therapy. Since
The methylnaltrexone license includes intellectual property from the University of Chicago, Progenics Pharmaceuticals and Wyeth Pharmaceuticals, including patents and applications with expiration dates that will range from 2017
Tamiflu was invented by Gilead Sciences and licensed to F Hoffmann-La Roche in 1996. In the notice letter, Natco requested permission to manufacture and market a generic version
The US Patent No 7,865,534, titled ‘System, Method and Apparatus for Assembling and Mining Life Science Data,’ describes an in silico-based data storage system that allows scientists to
The facility, equipped with HPLC, UPLC, GC, UV, IR, DSC, KF and others, is expected to offer full-service, integrated clinical packaging, drug supply management and technology solutions to
Carter was most recently Proteon Therapeutics senior vice president and CRO where she was responsible for the company’s worldwide regulatory and quality functions. Prior to this, she was
The latest of Teradata’s industry LDMs will benefit life sciences (including pharmaceutical) companies as they integrate, centralize and analyze data used across the business. The LS-LDM (developed to
The improvement in earnings for the current fiscal quarter is mainly due to higher revenues in its service and product segments as well as reductions in operating expenses.
The Institute, developed and managed by Tufts University’s School of Medicine and its Advancement Division, is a university-wide, global pharmaceutical partnering initiative designed to create and manage a
The locking cap uses precision ultrasonic welding technology from Dukane’s Ultrasonics Division for speed, accuracy, and precision manufacturing. Dukane worked with Cap-N-Lock from the concept stage and provided
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.